Background. Insulin resistance is common posttransplantation and contributes to both new onset diabetes after transplantation and the metabolic syndrome. Insulin resistance indexes have never been validated in transplant recipients on tacrolimus compared with cyclosporine, although it is more diabetogenic. We aimed to assess these indexes in renal transplant recipients on tacrolimus as primary immunosuppressant.Methods. Retrospective analysis of 76 frequently sampled, intravenous glucose tolerance tests (for insulin sensitivity) in 38 nondiabetic renal transplant recipients on tacrolimus-centered immunosuppression. Indexes tested were fasting glucose/insulin ratio, homeostasis model assessment (HOMA) index, I/HOMA, log (HOMA), quantitative ...
Aims: Tacrolimus (Tac) inhibits insulin secretion in a Tac-trough blood level dependent way early po...
Background: We investigated the changing patterns of insulin secretion and resistance and risk facto...
Transplantation is the preferred organ replacement therapy for most patients with end-stage renal di...
OBJECTIVE: The purpose of this study was to investigate the validity of established insulin resistan...
OBJECTIVE - The purpose of this study was to investigate the validity of established insulin resista...
Background. New-onset diabetes after transplantation is an important complication of renal transplan...
BACKGROUND: Insulin resistance is considered to play an important role in the development of cardiov...
Background. Insulin resistance is considered to play an important role in the development of cardiov...
Background. β-Cell dysfunction and insulin resistance combine to cause new-onset diabetes after tran...
Background. beta-Cell dysfunction and insulin resistance combine to cause new-onset diabetes after t...
Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either...
OBJECTIVE — To ascertain whether simple indexes of insulin sensitivity based on a fasting blood samp...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The long-term effects of tacrolimus and cyclosporine on pancreatic islet cell function in renal tran...
Aims: Tacrolimus (Tac) inhibits insulin secretion in a Tac-trough blood level dependent way early po...
Background: We investigated the changing patterns of insulin secretion and resistance and risk facto...
Transplantation is the preferred organ replacement therapy for most patients with end-stage renal di...
OBJECTIVE: The purpose of this study was to investigate the validity of established insulin resistan...
OBJECTIVE - The purpose of this study was to investigate the validity of established insulin resista...
Background. New-onset diabetes after transplantation is an important complication of renal transplan...
BACKGROUND: Insulin resistance is considered to play an important role in the development of cardiov...
Background. Insulin resistance is considered to play an important role in the development of cardiov...
Background. β-Cell dysfunction and insulin resistance combine to cause new-onset diabetes after tran...
Background. beta-Cell dysfunction and insulin resistance combine to cause new-onset diabetes after t...
Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either...
OBJECTIVE — To ascertain whether simple indexes of insulin sensitivity based on a fasting blood samp...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The pathophysiology underlying new-onset diabetes after transplantation (NODAT) is unresolved. We ob...
The long-term effects of tacrolimus and cyclosporine on pancreatic islet cell function in renal tran...
Aims: Tacrolimus (Tac) inhibits insulin secretion in a Tac-trough blood level dependent way early po...
Background: We investigated the changing patterns of insulin secretion and resistance and risk facto...
Transplantation is the preferred organ replacement therapy for most patients with end-stage renal di...